Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Oncorus selloff has nothing to do with fundamentals, says Piper Sandler » 04:51
04/19/21
04/19
04:51
04/19/21
04:51
ONCR

Oncorus

$13.87 /

-0.37 (-2.60%)

, REPL

Replimune Group

$29.96 /

-1.27 (-4.07%)

Piper Sandler analyst…

Piper Sandler analyst Christopher Raymond is a buyer of Oncorus (ONCR) following the recent selloff saying the pullback has nothing to do with fundamentals. The selloff appears to be related to "repetitive misinformation" in the market regarding both the design and clinical execution of lead program ONCR-177, Raymond tells investors in a research note. The analyst says that while some of 58% year-to-date pullback can be blamed on the company's recent financing, he's hearing increasingly from investors that "misleading counter-detail points" first put forth by competitor Replimune Group (REPL) last fall are surfacing again. He keeps an Overweight rating on Oncorus with a $40 price target.

ShowHide Related Items >><<
REPL Replimune Group
$29.96 /

-1.27 (-4.07%)

ONCR Oncorus
$13.87 /

-0.37 (-2.60%)

ONCR Oncorus
$13.87 /

-0.37 (-2.60%)

03/16/21
Fly Intel: Top five analyst initiations
03/16/21 Maxim
Oncorus initiated with a Buy at Maxim
11/11/20 Piper Sandler
Oncorus timelines remain on track after Q3 results, says Piper Sandler
10/27/20 Jefferies
Oncorus initiated with a Buy at Jefferies
REPL Replimune Group
$29.96 /

-1.27 (-4.07%)

02/05/21 H.C. Wainwright
Replimune Group price target raised to $60 from $58 at H.C. Wainwright
12/16/20 Wedbush
Replimune Group, Harpoon Therapeutics removed from Best Ideas List at Wedbush
11/17/20 BTIG
Replimune Group initiated with a Buy at BTIG
11/10/20 H.C. Wainwright
Replimune Group price target raised to $58 from $54 at H.C. Wainwright
REPL Replimune Group
$29.96 /

-1.27 (-4.07%)

ONCR Oncorus
$13.87 /

-0.37 (-2.60%)

  • 12
    Feb
  • 22
    Oct
  • 02
    Oct
  • 09
    Jun
REPL Replimune Group
$29.96 /

-1.27 (-4.07%)

REPL Replimune Group
$29.96 /

-1.27 (-4.07%)

ONCR Oncorus
$13.87 /

-0.37 (-2.60%)

Conference/Events
Oncorus management to meet virtually with Piper Sandler » 04:55
04/16/21
04/16
04:55
04/16/21
04:55
ONCR

Oncorus

$14.24 /

+0.19 (+1.35%)

Virtual Meeting to be…

Virtual Meeting to be held April 14-16 hosted by Piper Sandler.

ShowHide Related Items >><<
ONCR Oncorus
$14.24 /

+0.19 (+1.35%)

ONCR Oncorus
$14.24 /

+0.19 (+1.35%)

03/16/21
Fly Intel: Top five analyst initiations
03/16/21 Maxim
Oncorus initiated with a Buy at Maxim
11/11/20 Piper Sandler
Oncorus timelines remain on track after Q3 results, says Piper Sandler
10/27/20 Jefferies
Oncorus initiated with a Buy at Jefferies
ONCR Oncorus
$14.24 /

+0.19 (+1.35%)

  • 12
    Feb
  • 02
    Oct
ONCR Oncorus
$14.24 /

+0.19 (+1.35%)

Conference/Events
Oncorus management to meet virtually with Piper Sandler » 07:40
04/15/21
04/15
07:40
04/15/21
07:40
ONCR

Oncorus

$14.05 /

+0.04 (+0.29%)

Virtual Meeting to be…

Virtual Meeting to be held April 14-16 hosted by Piper Sandler.

ShowHide Related Items >><<
ONCR Oncorus
$14.05 /

+0.04 (+0.29%)

ONCR Oncorus
$14.05 /

+0.04 (+0.29%)

03/16/21
Fly Intel: Top five analyst initiations
03/16/21 Maxim
Oncorus initiated with a Buy at Maxim
11/11/20 Piper Sandler
Oncorus timelines remain on track after Q3 results, says Piper Sandler
10/27/20 Jefferies
Oncorus initiated with a Buy at Jefferies
ONCR Oncorus
$14.05 /

+0.04 (+0.29%)

  • 12
    Feb
  • 02
    Oct
ONCR Oncorus
$14.05 /

+0.04 (+0.29%)

Over a month ago
Conference/Events
Maxim Group to hold a virtual conference » 04:55
03/18/21
03/18
04:55
03/18/21
04:55
CNSP

CNS Pharmaceuticals

$2.85 /

+0.18 (+6.74%)

, KTRA

Kintara Therapeutics

$2.14 /

-0.02 (-0.93%)

, PSTV

Plus Therapeutics

$2.85 /

+0.08 (+2.89%)

, TCON

Tracon Pharmaceuticals

$9.30 /

+0.2 (+2.20%)

, MDNA

Medicenna Therapeutics

$4.01 /

-0.01 (-0.25%)

, INO

Inovio

$10.53 /

+0.07 (+0.67%)

, ONCR

Oncorus

$16.33 /

-0.485 (-2.88%)

, GOVX

GeoVax Labs

$5.73 /

+0.39 (+7.30%)

, HTBX

Heat Biologics

$8.66 /

+0.3 (+3.59%)

, SLS

Sellas Life Sciences

$11.67 /

+1.25 (+12.00%)

, PLSE

Pulse Biosciences

$25.60 /

-0.4 (-1.54%)

, SRTS

Sensus Healthcare

$4.39 /

-0.02 (-0.45%)

, VERO

Venus Concept

$2.77 /

+0.18 (+6.95%)

, SOLY

Soliton

$16.86 /

-0.67 (-3.82%)

, CLXPF

Cybin

$0.00 /

+ (+0.00%)

, MMED

Midas Medici

$0.00 /

+ (+0.00%)

, CHFS

CHF Solutions

$6.19 /

-1.15 (-15.67%)

, ECOR

electroCore

$2.19 /

+0.095 (+4.53%)

, BIOL

Biolase

$1.01 /

+0.0553 (+5.79%)

, AEMD

Aethlon Medical

$2.25 /

-0.06 (-2.60%)

, ZSAN

Zosano Pharma

$1.47 /

+0.14 (+10.53%)

, NLSP

NLS Pharmaceutics

$4.51 /

+0.15 (+3.44%)

, CYTH

Cyclo Therapeutics

$12.80 /

+0.41 (+3.31%)

, MNPR

Monopar Therapeutics

$7.38 /

-0.11 (-1.47%)

Inaugural Emerging Growth…

Inaugural Emerging Growth Virtual Conference 2021 will be held on March 17-19.

ShowHide Related Items >><<
ZSAN Zosano Pharma
$1.47 /

+0.14 (+10.53%)

TCON Tracon Pharmaceuticals
$9.30 /

+0.2 (+2.20%)

SRTS Sensus Healthcare
$4.39 /

-0.02 (-0.45%)

SOLY Soliton
$16.86 /

-0.67 (-3.82%)

SLS Sellas Life Sciences
$11.67 /

+1.25 (+12.00%)

PSTV Plus Therapeutics
$2.85 /

+0.08 (+2.89%)

PLSE Pulse Biosciences
$25.60 /

-0.4 (-1.54%)

ONCR Oncorus
$16.33 /

-0.485 (-2.88%)

NLSP NLS Pharmaceutics
$4.51 /

+0.15 (+3.44%)

MNPR Monopar Therapeutics
$7.38 /

-0.11 (-1.47%)

MDNA Medicenna Therapeutics
$4.01 /

-0.01 (-0.25%)

KTRA Kintara Therapeutics
$2.14 /

-0.02 (-0.93%)

INO Inovio
$10.53 /

+0.07 (+0.67%)

HTBX Heat Biologics
$8.66 /

+0.3 (+3.59%)

GOVX GeoVax Labs
$5.73 /

+0.39 (+7.30%)

ECOR electroCore
$2.19 /

+0.095 (+4.53%)

CYTH Cyclo Therapeutics
$12.80 /

+0.41 (+3.31%)

CNSP CNS Pharmaceuticals
$2.85 /

+0.18 (+6.74%)

CHFS CHF Solutions
$6.19 /

-1.15 (-15.67%)

BIOL Biolase
$1.01 /

+0.0553 (+5.79%)

AEMD Aethlon Medical
$2.25 /

-0.06 (-2.60%)

CNSP CNS Pharmaceuticals
$2.85 /

+0.18 (+6.74%)

02/02/21 Brookline
CNS Pharmaceuticals initiated with a Buy at Brookline
12/28/20
Fly Intel: Top five analyst calls
12/28/20 Ladenburg
CNS Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
08/24/20 Ladenburg
CNS Pharmaceuticals initiated with a Buy at Ladenburg
KTRA Kintara Therapeutics
$2.14 /

-0.02 (-0.93%)

09/14/20 Aegis
Kintara Therapeutics initiated with a Buy at Aegis
PSTV Plus Therapeutics
$2.85 /

+0.08 (+2.89%)

02/11/21
Fly Intel: Top five analyst initiations
02/11/21 H.C. Wainwright
Plus Therapeutics initiated with a Buy at H.C. Wainwright
01/25/21 Ladenburg
Plus Therapeutics initiated with a Buy at Ladenburg
10/16/20
Fly Intel: Top five analyst initiations
TCON Tracon Pharmaceuticals
$9.30 /

+0.2 (+2.20%)

02/10/21
Fly Intel: Top five analyst initiations
02/10/21 Maxim
Tracon Pharmaceuticals initiated with a Buy at Maxim
12/04/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $12 from $7 at H.C. Wainwright
09/17/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $7 from $4 at H.C. Wainwright
MDNA Medicenna Therapeutics
$4.01 /

-0.01 (-0.25%)

12/17/20 Oppenheimer
Medicenna Therapeutics initiated with an Outperform at Oppenheimer
09/10/20 H.C. Wainwright
Medicenna Therapeutics initiated with a Buy at H.C. Wainwright
INO Inovio
$10.53 /

+0.07 (+0.67%)

03/02/21 Piper Sandler
Piper lowers Inovio target to $7 after 'decidedly negative' update
02/11/21 Oppenheimer
Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target
02/11/21 Oppenheimer
Inovio initiated with an Outperform at Oppenheimer
02/09/21 Maxim
Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
ONCR Oncorus
$16.33 /

-0.485 (-2.88%)

03/16/21
Fly Intel: Top five analyst initiations
03/16/21 Maxim
Oncorus initiated with a Buy at Maxim
11/11/20 Piper Sandler
Oncorus timelines remain on track after Q3 results, says Piper Sandler
10/27/20 Jefferies
Oncorus initiated with a Buy at Jefferies
GOVX GeoVax Labs
$5.73 /

+0.39 (+7.30%)

11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
HTBX Heat Biologics
$8.66 /

+0.3 (+3.59%)

03/02/21 Cantor Fitzgerald
Heat Biologics initiated with an Overweight at Cantor Fitzgerald
02/09/21 Alliance Global Partners
Heat Biologics price target raised to $40 from $5 at Alliance Global Partners
12/24/20 B. Riley
Heat Biologics transferred with a Buy at B. Riley Securities
SLS Sellas Life Sciences
$11.67 /

+1.25 (+12.00%)

12/21/20 Alliance Global Partners
Alliance Global Partners keeps Buy on Sellas following data from trials
PLSE Pulse Biosciences
$25.60 /

-0.4 (-1.54%)

03/11/21 Maxim
Pulse Biosciences initiated with a Buy at Maxim
03/11/21 Maxim
Pulse Biosciences initiated with a Buy at Maxim
02/04/21 H.C. Wainwright
Pulse Biosciences price target raised to $46 from $40 at H.C. Wainwright
01/26/21 H.C. Wainwright
Pulse Biosciences price target raised to $40 from $16 at H.C. Wainwright
SRTS Sensus Healthcare
$4.39 /

-0.02 (-0.45%)

03/01/21 H.C. Wainwright
Sensus Healthcare price target raised to $6 from $4 at H.C. Wainwright
02/26/21 Northland
Northland upgrades Sensus Healthcare to Outperform after 'strong' Q4 report
02/26/21 Northland
Sensus Healthcare upgraded to Outperform from Market Perform at Northland
12/16/20 Northland
Sensus Healthcare downgraded to Market Perform on valuation at Northland
VERO Venus Concept
$2.77 /

+0.18 (+6.95%)

12/29/20 BTIG
Venus Concept flying under the radar, says BTIG
12/08/20 Stifel
Venus Concept initiated with a Hold at Stifel
12/08/20 Stifel
Venus Concept initiated with a Hold at Stifel
11/16/20 Oppenheimer
Venus Concept upgraded to Outperform with $4 target at Oppenheimer
SOLY Soliton
$16.86 /

-0.67 (-3.82%)

03/08/21 Maxim
Soliton's multiple 2021 trials to expand its pipeline, says Maxim
02/08/21 Maxim
Soliton price target raised to $25 from $22 at Maxim
02/02/21 Cantor Fitzgerald
Soliton price target raised to $20 from $12 at Cantor Fitzgerald
07/15/20 Cantor Fitzgerald
Soliton initiated with an Overweight at Cantor Fitzgerald
CLXPF Cybin
$0.00 /

+ (+0.00%)

03/15/21 Canaccord
Cybin initiated with a Buy at Canaccord
01/14/21 Stifel
Cybin initiated with a Speculative Buy at Stifel
MMED Midas Medici
$0.00 /

+ (+0.00%)

CHFS CHF Solutions
$6.19 /

-1.15 (-15.67%)

10/21/20 Maxim
CHF Solutions price target lowered to $20 from $45 at Maxim
06/05/20 Maxim
CHF Solutions initiated with a Buy at Maxim
ECOR electroCore
$2.19 /

+0.095 (+4.53%)

10/22/20 Brookline
electroCore initiated with a Buy at Brookline
09/30/20
Fly Intel: Top five analyst initiationsNewPage
09/30/20 Maxim
electroCore initiated with a Buy at Maxim
09/30/20 Maxim
electroCore initiated with a Buy at Maxim
BIOL Biolase
$1.01 /

+0.0553 (+5.79%)

01/26/21 Maxim
Biolase price target raised to $2 at Maxim on 'strong' preliminary Q4 revenue
10/14/20 Maxim
Biolase initiated with a Buy at Maxim
04/09/20
Biolase supplying ventilators 'highly encouraging,' says Dougherty
AEMD Aethlon Medical
$2.25 /

-0.06 (-2.60%)

01/08/21
Fly Intel: Top five analyst initiations
01/08/21 Maxim
Aethlon Medical initiated with a Buy at Maxim
ZSAN Zosano Pharma
$1.47 /

+0.14 (+10.53%)

03/15/21 Maxim
Zosano Pharma price target raised to $2.50 from $1.50 at Maxim
10/22/20 BTIG
Zosano Pharma price target lowered to $2 from $7 at BTIG
10/02/20 H.C. Wainwright
Zosano Pharma price target lowered to $2.50 from $4 at H.C. Wainwright
09/14/20 BTIG
Satsuma setback a positive for Zosano Pharma, says BTIG
NLSP NLS Pharmaceutics
$4.51 /

+0.15 (+3.44%)

03/12/21 Brookline
NLS Pharmaceutics initiated with a Buy at Brookline
03/03/21 Maxim
NLS Pharmaceutics initiated with a Buy at Maxim
CYTH Cyclo Therapeutics
$12.80 /

+0.41 (+3.31%)

02/10/21 Maxim
Cyclo Therapeutics price target raised to $25 from $12 at Maxim
12/17/20 Maxim
Cyclo Therapeutics initiated with a Buy at Maxim
MNPR Monopar Therapeutics
$7.38 /

-0.11 (-1.47%)

01/28/21 Roth Capital
Monopar Therapeutics initiated with a Buy at Roth Capital
09/24/20 Maxim
Monopar Therapeutics initiated with a Buy at Maxim
06/16/20 JonesTrading
JonesTrading backs Buy on Monoper after NorthStar Medical collaboration
ZSAN Zosano Pharma
$1.47 /

+0.14 (+10.53%)

VERO Venus Concept
$2.77 /

+0.18 (+6.95%)

TCON Tracon Pharmaceuticals
$9.30 /

+0.2 (+2.20%)

SRTS Sensus Healthcare
$4.39 /

-0.02 (-0.45%)

SOLY Soliton
$16.86 /

-0.67 (-3.82%)

SLS Sellas Life Sciences
$11.67 /

+1.25 (+12.00%)

PSTV Plus Therapeutics
$2.85 /

+0.08 (+2.89%)

ONCR Oncorus
$16.33 /

-0.485 (-2.88%)

MNPR Monopar Therapeutics
$7.38 /

-0.11 (-1.47%)

MDNA Medicenna Therapeutics
$4.01 /

-0.01 (-0.25%)

KTRA Kintara Therapeutics
$2.14 /

-0.02 (-0.93%)

INO Inovio
$10.53 /

+0.07 (+0.67%)

HTBX Heat Biologics
$8.66 /

+0.3 (+3.59%)

ECOR electroCore
$2.19 /

+0.095 (+4.53%)

CHFS CHF Solutions
$6.19 /

-1.15 (-15.67%)

BIOL Biolase
$1.01 /

+0.0553 (+5.79%)

AEMD Aethlon Medical
$2.25 /

-0.06 (-2.60%)

  • 17
    Mar
  • 12
    Feb
  • 29
    Jan
  • 21
    Jan
  • 23
    Dec
  • 22
    Dec
  • 02
    Oct
  • 25
    Sep
  • 01
    Sep
  • 26
    Jun
SLS Sellas Life Sciences
$11.67 /

+1.25 (+12.00%)

INO Inovio
$10.53 /

+0.07 (+0.67%)

ZSAN Zosano Pharma
$1.47 /

+0.14 (+10.53%)

VERO Venus Concept
$2.77 /

+0.18 (+6.95%)

ONCR Oncorus
$16.33 /

-0.485 (-2.88%)

NLSP NLS Pharmaceutics
$4.51 /

+0.15 (+3.44%)

MDNA Medicenna Therapeutics
$4.01 /

-0.01 (-0.25%)

INO Inovio
$10.53 /

+0.07 (+0.67%)

HTBX Heat Biologics
$8.66 /

+0.3 (+3.59%)

GOVX GeoVax Labs
$5.73 /

+0.39 (+7.30%)

TCON Tracon Pharmaceuticals
$9.30 /

+0.2 (+2.20%)

SLS Sellas Life Sciences
$11.67 /

+1.25 (+12.00%)

ONCR Oncorus
$16.33 /

-0.485 (-2.88%)

INO Inovio
$10.53 /

+0.07 (+0.67%)

HTBX Heat Biologics
$8.66 /

+0.3 (+3.59%)

Conference/Events
Maxim Group to hold a virtual conference » 09:48
03/17/21
03/17
09:48
03/17/21
09:48
CNSP

CNS Pharmaceuticals

$2.65 /

-0.02 (-0.75%)

, KTRA

Kintara Therapeutics

$2.08 /

-0.08 (-3.70%)

, PSTV

Plus Therapeutics

$2.75 /

-0.02 (-0.72%)

, TCON

Tracon Pharmaceuticals

$8.80 /

-0.3 (-3.30%)

, MDNA

Medicenna Therapeutics

$4.00 /

-0.02 (-0.50%)

, INO

Inovio

$10.33 /

-0.13 (-1.24%)

, ONCR

Oncorus

$16.50 /

-0.315 (-1.87%)

, GOVX

GeoVax Labs

$5.40 /

+0.06 (+1.12%)

, HTBX

Heat Biologics

$8.12 /

-0.24 (-2.87%)

, SLS

Sellas Life Sciences

$10.42 /

+ (+0.00%)

, PLSE

Pulse Biosciences

$26.20 /

+0.2 (+0.77%)

, SRTS

Sensus Healthcare

$4.40 /

-0.01 (-0.23%)

, VERO

Venus Concept

$2.43 /

-0.16 (-6.18%)

, SOLY

Soliton

$16.80 /

-0.73 (-4.16%)

, CLXPF

Cybin

$0.00 /

+ (+0.00%)

, MMED

Midas Medici

$0.00 /

+ (+0.00%)

, CHFS

CHF Solutions

$5.87 /

-1.47 (-20.03%)

, ECOR

electroCore

$2.07 /

-0.025 (-1.19%)

, BIOL

Biolase

$0.90 /

-0.0547 (-5.73%)

, AEMD

Aethlon Medical

$2.22 /

-0.09 (-3.90%)

, ZSAN

Zosano Pharma

$1.38 /

+0.05 (+3.76%)

, NLSP

NLS Pharmaceutics

$4.32 /

-0.04 (-0.92%)

, CYTH

Cyclo Therapeutics

$11.56 /

-0.83 (-6.70%)

, MNPR

Monopar Therapeutics

$7.40 /

-0.09 (-1.20%)

Inaugural Emerging Growth…

Inaugural Emerging Growth Virtual Conference 2021 will be held on March 17-19.

ShowHide Related Items >><<
ZSAN Zosano Pharma
$1.38 /

+0.05 (+3.76%)

TCON Tracon Pharmaceuticals
$8.80 /

-0.3 (-3.30%)

SRTS Sensus Healthcare
$4.40 /

-0.01 (-0.23%)

SOLY Soliton
$16.80 /

-0.73 (-4.16%)

SLS Sellas Life Sciences
$10.42 /

+ (+0.00%)

PSTV Plus Therapeutics
$2.75 /

-0.02 (-0.72%)

PLSE Pulse Biosciences
$26.20 /

+0.2 (+0.77%)

ONCR Oncorus
$16.50 /

-0.315 (-1.87%)

NLSP NLS Pharmaceutics
$4.32 /

-0.04 (-0.92%)

MNPR Monopar Therapeutics
$7.40 /

-0.09 (-1.20%)

MDNA Medicenna Therapeutics
$4.00 /

-0.02 (-0.50%)

KTRA Kintara Therapeutics
$2.08 /

-0.08 (-3.70%)

INO Inovio
$10.33 /

-0.13 (-1.24%)

HTBX Heat Biologics
$8.12 /

-0.24 (-2.87%)

GOVX GeoVax Labs
$5.40 /

+0.06 (+1.12%)

ECOR electroCore
$2.07 /

-0.025 (-1.19%)

CYTH Cyclo Therapeutics
$11.56 /

-0.83 (-6.70%)

CNSP CNS Pharmaceuticals
$2.65 /

-0.02 (-0.75%)

CHFS CHF Solutions
$5.87 /

-1.47 (-20.03%)

BIOL Biolase
$0.90 /

-0.0547 (-5.73%)

AEMD Aethlon Medical
$2.22 /

-0.09 (-3.90%)

CNSP CNS Pharmaceuticals
$2.65 /

-0.02 (-0.75%)

02/02/21 Brookline
CNS Pharmaceuticals initiated with a Buy at Brookline
12/28/20
Fly Intel: Top five analyst calls
12/28/20 Ladenburg
CNS Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
08/24/20 Ladenburg
CNS Pharmaceuticals initiated with a Buy at Ladenburg
KTRA Kintara Therapeutics
$2.08 /

-0.08 (-3.70%)

09/14/20 Aegis
Kintara Therapeutics initiated with a Buy at Aegis
PSTV Plus Therapeutics
$2.75 /

-0.02 (-0.72%)

02/11/21
Fly Intel: Top five analyst initiations
02/11/21 H.C. Wainwright
Plus Therapeutics initiated with a Buy at H.C. Wainwright
01/25/21 Ladenburg
Plus Therapeutics initiated with a Buy at Ladenburg
10/16/20
Fly Intel: Top five analyst initiations
TCON Tracon Pharmaceuticals
$8.80 /

-0.3 (-3.30%)

02/10/21
Fly Intel: Top five analyst initiations
02/10/21 Maxim
Tracon Pharmaceuticals initiated with a Buy at Maxim
12/04/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $12 from $7 at H.C. Wainwright
09/17/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $7 from $4 at H.C. Wainwright
MDNA Medicenna Therapeutics
$4.00 /

-0.02 (-0.50%)

12/17/20 Oppenheimer
Medicenna Therapeutics initiated with an Outperform at Oppenheimer
09/10/20 H.C. Wainwright
Medicenna Therapeutics initiated with a Buy at H.C. Wainwright
INO Inovio
$10.33 /

-0.13 (-1.24%)

03/02/21 Piper Sandler
Piper lowers Inovio target to $7 after 'decidedly negative' update
02/11/21 Oppenheimer
Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target
02/11/21 Oppenheimer
Inovio initiated with an Outperform at Oppenheimer
02/09/21 Maxim
Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
ONCR Oncorus
$16.50 /

-0.315 (-1.87%)

03/16/21
Fly Intel: Top five analyst initiations
03/16/21 Maxim
Oncorus initiated with a Buy at Maxim
11/11/20 Piper Sandler
Oncorus timelines remain on track after Q3 results, says Piper Sandler
10/27/20 Jefferies
Oncorus initiated with a Buy at Jefferies
GOVX GeoVax Labs
$5.40 /

+0.06 (+1.12%)

11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
HTBX Heat Biologics
$8.12 /

-0.24 (-2.87%)

03/02/21 Cantor Fitzgerald
Heat Biologics initiated with an Overweight at Cantor Fitzgerald
02/09/21 Alliance Global Partners
Heat Biologics price target raised to $40 from $5 at Alliance Global Partners
12/24/20 B. Riley
Heat Biologics transferred with a Buy at B. Riley Securities
SLS Sellas Life Sciences
$10.42 /

+ (+0.00%)

12/21/20 Alliance Global Partners
Alliance Global Partners keeps Buy on Sellas following data from trials
PLSE Pulse Biosciences
$26.20 /

+0.2 (+0.77%)

03/11/21 Maxim
Pulse Biosciences initiated with a Buy at Maxim
03/11/21 Maxim
Pulse Biosciences initiated with a Buy at Maxim
02/04/21 H.C. Wainwright
Pulse Biosciences price target raised to $46 from $40 at H.C. Wainwright
01/26/21 H.C. Wainwright
Pulse Biosciences price target raised to $40 from $16 at H.C. Wainwright
SRTS Sensus Healthcare
$4.40 /

-0.01 (-0.23%)

03/01/21 H.C. Wainwright
Sensus Healthcare price target raised to $6 from $4 at H.C. Wainwright
02/26/21 Northland
Northland upgrades Sensus Healthcare to Outperform after 'strong' Q4 report
02/26/21 Northland
Sensus Healthcare upgraded to Outperform from Market Perform at Northland
12/16/20 Northland
Sensus Healthcare downgraded to Market Perform on valuation at Northland
VERO Venus Concept
$2.43 /

-0.16 (-6.18%)

12/29/20 BTIG
Venus Concept flying under the radar, says BTIG
12/08/20 Stifel
Venus Concept initiated with a Hold at Stifel
12/08/20 Stifel
Venus Concept initiated with a Hold at Stifel
11/16/20 Oppenheimer
Venus Concept upgraded to Outperform with $4 target at Oppenheimer
SOLY Soliton
$16.80 /

-0.73 (-4.16%)

03/08/21 Maxim
Soliton's multiple 2021 trials to expand its pipeline, says Maxim
02/08/21 Maxim
Soliton price target raised to $25 from $22 at Maxim
02/02/21 Cantor Fitzgerald
Soliton price target raised to $20 from $12 at Cantor Fitzgerald
07/15/20 Cantor Fitzgerald
Soliton initiated with an Overweight at Cantor Fitzgerald
CLXPF Cybin
$0.00 /

+ (+0.00%)

03/15/21 Canaccord
Cybin initiated with a Buy at Canaccord
01/14/21 Stifel
Cybin initiated with a Speculative Buy at Stifel
MMED Midas Medici
$0.00 /

+ (+0.00%)

CHFS CHF Solutions
$5.87 /

-1.47 (-20.03%)

10/21/20 Maxim
CHF Solutions price target lowered to $20 from $45 at Maxim
06/05/20 Maxim
CHF Solutions initiated with a Buy at Maxim
ECOR electroCore
$2.07 /

-0.025 (-1.19%)

10/22/20 Brookline
electroCore initiated with a Buy at Brookline
09/30/20
Fly Intel: Top five analyst initiationsNewPage
09/30/20 Maxim
electroCore initiated with a Buy at Maxim
09/30/20 Maxim
electroCore initiated with a Buy at Maxim
BIOL Biolase
$0.90 /

-0.0547 (-5.73%)

01/26/21 Maxim
Biolase price target raised to $2 at Maxim on 'strong' preliminary Q4 revenue
10/14/20 Maxim
Biolase initiated with a Buy at Maxim
04/09/20
Biolase supplying ventilators 'highly encouraging,' says Dougherty
AEMD Aethlon Medical
$2.22 /

-0.09 (-3.90%)

01/08/21
Fly Intel: Top five analyst initiations
01/08/21 Maxim
Aethlon Medical initiated with a Buy at Maxim
ZSAN Zosano Pharma
$1.38 /

+0.05 (+3.76%)

03/15/21 Maxim
Zosano Pharma price target raised to $2.50 from $1.50 at Maxim
10/22/20 BTIG
Zosano Pharma price target lowered to $2 from $7 at BTIG
10/02/20 H.C. Wainwright
Zosano Pharma price target lowered to $2.50 from $4 at H.C. Wainwright
09/14/20 BTIG
Satsuma setback a positive for Zosano Pharma, says BTIG
NLSP NLS Pharmaceutics
$4.32 /

-0.04 (-0.92%)

03/12/21 Brookline
NLS Pharmaceutics initiated with a Buy at Brookline
03/03/21 Maxim
NLS Pharmaceutics initiated with a Buy at Maxim
CYTH Cyclo Therapeutics
$11.56 /

-0.83 (-6.70%)

02/10/21 Maxim
Cyclo Therapeutics price target raised to $25 from $12 at Maxim
12/17/20 Maxim
Cyclo Therapeutics initiated with a Buy at Maxim
MNPR Monopar Therapeutics
$7.40 /

-0.09 (-1.20%)

01/28/21 Roth Capital
Monopar Therapeutics initiated with a Buy at Roth Capital
09/24/20 Maxim
Monopar Therapeutics initiated with a Buy at Maxim
06/16/20 JonesTrading
JonesTrading backs Buy on Monoper after NorthStar Medical collaboration
ZSAN Zosano Pharma
$1.38 /

+0.05 (+3.76%)

VERO Venus Concept
$2.43 /

-0.16 (-6.18%)

TCON Tracon Pharmaceuticals
$8.80 /

-0.3 (-3.30%)

SRTS Sensus Healthcare
$4.40 /

-0.01 (-0.23%)

SOLY Soliton
$16.80 /

-0.73 (-4.16%)

SLS Sellas Life Sciences
$10.42 /

+ (+0.00%)

PSTV Plus Therapeutics
$2.75 /

-0.02 (-0.72%)

ONCR Oncorus
$16.50 /

-0.315 (-1.87%)

MNPR Monopar Therapeutics
$7.40 /

-0.09 (-1.20%)

MDNA Medicenna Therapeutics
$4.00 /

-0.02 (-0.50%)

KTRA Kintara Therapeutics
$2.08 /

-0.08 (-3.70%)

INO Inovio
$10.33 /

-0.13 (-1.24%)

HTBX Heat Biologics
$8.12 /

-0.24 (-2.87%)

ECOR electroCore
$2.07 /

-0.025 (-1.19%)

CHFS CHF Solutions
$5.87 /

-1.47 (-20.03%)

BIOL Biolase
$0.90 /

-0.0547 (-5.73%)

AEMD Aethlon Medical
$2.22 /

-0.09 (-3.90%)

  • 17
    Mar
  • 12
    Feb
  • 29
    Jan
  • 21
    Jan
  • 23
    Dec
  • 22
    Dec
  • 02
    Oct
  • 25
    Sep
  • 01
    Sep
  • 26
    Jun
SLS Sellas Life Sciences
$10.42 /

+ (+0.00%)

INO Inovio
$10.33 /

-0.13 (-1.24%)

ZSAN Zosano Pharma
$1.38 /

+0.05 (+3.76%)

VERO Venus Concept
$2.43 /

-0.16 (-6.18%)

ONCR Oncorus
$16.50 /

-0.315 (-1.87%)

NLSP NLS Pharmaceutics
$4.32 /

-0.04 (-0.92%)

MDNA Medicenna Therapeutics
$4.00 /

-0.02 (-0.50%)

INO Inovio
$10.33 /

-0.13 (-1.24%)

HTBX Heat Biologics
$8.12 /

-0.24 (-2.87%)

GOVX GeoVax Labs
$5.40 /

+0.06 (+1.12%)

TCON Tracon Pharmaceuticals
$8.80 /

-0.3 (-3.30%)

SLS Sellas Life Sciences
$10.42 /

+ (+0.00%)

ONCR Oncorus
$16.50 /

-0.315 (-1.87%)

INO Inovio
$10.33 /

-0.13 (-1.24%)

HTBX Heat Biologics
$8.12 /

-0.24 (-2.87%)

Initiation
Fly Intel: Top five analyst initiations » 09:54
03/16/21
03/16
09:54
03/16/21
09:54
SVRA

Savara

$2.91 /

+1.15 (+65.34%)

, RBLX

Roblox

$74.86 /

+2.71 (+3.76%)

, TTGT

TechTarget

$78.30 /

-2.5 (-3.09%)

, CCX

Skillsoft

$10.04 /

+0.05 (+0.50%)

, ONCR

Oncorus

$16.77 /

+0.47 (+2.88%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Savara (SVRA) initiated with an Overweight at Piper Sandler. 2. Roblox (RBLX) initiated with a Buy at Stifel. 3. TechTarget (TTGT) initiated with a Market Perform at Cowen. 4. Churchill Capital Corp II (CCX) initiated with a Buy at Benchmark. 5. Oncorus (ONCR) initiated with a Buy at Maxim. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
TTGT TechTarget
$78.30 /

-2.5 (-3.09%)

SVRA Savara
$2.91 /

+1.15 (+65.34%)

RBLX Roblox
$74.86 /

+2.71 (+3.76%)

ONCR Oncorus
$16.77 /

+0.47 (+2.88%)

CCX Skillsoft
$10.04 /

+0.05 (+0.50%)

SVRA Savara
$2.91 /

+1.15 (+65.34%)

03/16/21 Piper Sandler
Savara initiated with an Overweight at Piper Sandler
03/15/21 Oppenheimer
Savara initiated with an Outperform at Oppenheimer
12/15/20 H.C. Wainwright
Savara price target lowered to $3 from $6 at H.C. Wainwright
11/23/20 Evercore ISI
Savara resumed with an Outperform at Evercore ISI
RBLX Roblox
$74.86 /

+2.71 (+3.76%)

03/15/21 Stifel
Stifel starts 'compelling play' on content and social convergence Roblox at Buy
03/15/21 Stifel
Roblox initiated with a Buy at Stifel
TTGT TechTarget
$78.30 /

-2.5 (-3.09%)

03/16/21 Cowen
TechTarget initiated with a Market Perform at Cowen
02/18/21 Needham
TechTarget initiated with a Buy at Needham
02/18/21 Needham
TechTarget initiated with a Buy at Needham
02/11/21 Lake Street
TechTarget price target raised to $103 from $69 at Lake Street
CCX Skillsoft
$10.04 /

+0.05 (+0.50%)

03/16/21 Benchmark
Churchill Capital Corp II initiated with a Buy at Benchmark
ONCR Oncorus
$16.77 /

+0.47 (+2.88%)

03/16/21 Maxim
Oncorus initiated with a Buy at Maxim
11/11/20 Piper Sandler
Oncorus timelines remain on track after Q3 results, says Piper Sandler
10/27/20 Jefferies
Oncorus initiated with a Buy at Jefferies
10/27/20 Evercore ISI
Oncorus initiated with an Outperform at Evercore ISI
TTGT TechTarget
$78.30 /

-2.5 (-3.09%)

ONCR Oncorus
$16.77 /

+0.47 (+2.88%)

  • 11
    Mar
  • 12
    Feb
  • 02
    Oct
RBLX Roblox
$74.86 /

+2.71 (+3.76%)

TTGT TechTarget
$78.30 /

-2.5 (-3.09%)

RBLX Roblox
$74.86 /

+2.71 (+3.76%)

ONCR Oncorus
$16.77 /

+0.47 (+2.88%)

SVRA Savara
$2.91 /

+1.15 (+65.34%)

RBLX Roblox
$74.86 /

+2.71 (+3.76%)

ONCR Oncorus
$16.77 /

+0.47 (+2.88%)

CCX Skillsoft
$10.04 /

+0.05 (+0.50%)

Initiation
Oncorus initiated with a Buy at Maxim » 08:20
03/16/21
03/16
08:20
03/16/21
08:20
ONCR

Oncorus

$16.35 /

+0.125 (+0.77%)

Maxim analyst Naureen…

Maxim analyst Naureen Quibria initiated coverage of Oncorus with a Buy rating and $35 price target. The company's oHSV platform has been de-risked with targeting herpes simplex virus as its foundation, having demonstrated efficacy and safety in the clinic, the analyst tells investors in a research note. Quibria adds that Oncorus' technology offers a complementary approach to checkpoints whereby its oncolytic viral immunotherapies can "stimulate the host immune system to recruit T cells, turning a 'cold' tumor 'hot'", making oncolytic agents an "ideal combination" with other immunotherapies.

ShowHide Related Items >><<
ONCR Oncorus
$16.35 /

+0.125 (+0.77%)

ONCR Oncorus
$16.35 /

+0.125 (+0.77%)

11/11/20 Piper Sandler
Oncorus timelines remain on track after Q3 results, says Piper Sandler
10/27/20 Jefferies
Oncorus initiated with a Buy at Jefferies
10/27/20 Evercore ISI
Oncorus initiated with an Outperform at Evercore ISI
10/27/20 Piper Sandler
Oncorus initiated with an Overweight at Piper Sandler
ONCR Oncorus
$16.35 /

+0.125 (+0.77%)

  • 12
    Feb
  • 02
    Oct
ONCR Oncorus
$16.35 /

+0.125 (+0.77%)

ONCR Oncorus
$16.35 /

+0.125 (+0.77%)

Options
new option listings and one option delisting on March 10th » 08:30
03/10/21
03/10
08:30
03/10/21
08:30
BWAC

Better World Acquisition

$9.99 /

+0.03 (+0.30%)

, CONX

Conx

$10.03 /

-0.08 (-0.79%)

, DCRB

Decarbonization Plus Acquisition

$11.30 /

+0.5 (+4.63%)

, DMYI

dMY Technology Group, Inc. III

$11.31 /

+0.41 (+3.76%)

, GHVI

Gores Holdings VI

$15.94 /

+1.3 (+8.88%)

, GNRS

Greenrose Acquisition

$10.04 /

+ (+0.00%)

, HAAC

Health Assurance Acquisition

$10.63 /

+0.14 (+1.33%)

, HZON

Horizon Acquisition Corp. II

$10.88 /

+0.01 (+0.09%)

, IACA

Ion Acquisition 1

$10.94 /

+0.15 (+1.39%)

, IGAC

IG Acquisition

$9.96 /

+0.04 (+0.40%)

, LCY

Landcadia Holdings III

$10.40 /

+ (+0.00%)

, LEAP

Ribbit LEAP

$11.96 /

+0.35 (+3.01%)

, LFTR

Lefteris Acquisition

$10.21 /

+0.01 (+0.10%)

, LUXA

Lux Health Tech Acquisition

$10.57 /

+0.06 (+0.57%)

, MCMJ

Merida Merger Corp. I

$10.09 /

+0.115 (+1.15%)

, ONCR

Oncorus

$14.78 /

+0.72 (+5.12%)

, PIPP

Pine Island Acquisition

$10.39 /

+0.07 (+0.68%)

, RAAC

Revolution Acceleration Acquisition Corp

$10.51 /

-0.04 (-0.38%)

, RMGB

RMG Acquisition Corporation II

$10.31 /

-0.13 (-1.25%)

, SEAH

Sports Entertainment Acquisition

$10.01 /

+0.01 (+0.10%)

, SPNV

Supernova Partners Acquisition

$10.30 /

+0.09 (+0.88%)

, SYPR

Sypris Solutions

$3.26 /

+0.16 (+5.16%)

, TWCT

TWC Tech Holdings II

$10.02 /

-0.085 (-0.84%)

, WPF

Foley Trasimene Acquisition Corp.

$10.20 /

+0.065 (+0.64%)

, XPOA

DPCM Capital

$10.12 /

-0.07 (-0.69%)

, YALA

Yalla

$19.49 /

+1.57 (+8.76%)

, NK

NantKwest

$0.00 /

+ (+0.00%)

New option listings for…

New option listings for March 10th include Burgundy Technology Acquition Corporation (Class A Stock) (BTAQ), Better World Acquisition Corporation (BWAC), CONX Corporation (Class A Stock) (CONX), Decarbonization Plus Acquisition Corporation (Class A Stock) (DCRB), dMY Technology Group Inc III (Class A Stock) (DMYI), FG New America Acquisition Corp (Class A Stock) (FGNA), FirstMark Horizon Acquisition Corp (Class A Stock) (FMAC), Gores Holdings VI Inc (Class A Stock) (GHVI), Greenrose Axquisition Corporation (GNRS), Health Assurance Acquisition Corporation (Class A Stock) (HAAC), Horizon Acquisition Corporation II (Class A Stock) (HZON), ION Acquisition Corp 1 Ltd (Class A Stock) (IACA), ImmunityBio Inc (IBRX), IG Acquisition Corporation (Class A Stock) (IGAC), Landcadia Holdings III Inc (Class A Stock) (LCY), Ribbit LEAP Ltd (Class A Stock) (LEAP), Lefteris Acquisition Corporation (Class A Stock) (LFTR), Lux Health Tech Acquisition Corporation (Class A Stock) (LUXA), Merida Merger Corporation I (MCMJ), Oncorus Inc (ONCR), Pine Island Acquisition Corp (Class A Stock) (PIPP), Revolution Acceleration Acquisition Corporation (Class A Stock) (RAAC), RMG Acquisition Corporation II (Class A Stock) (RMGB), Sports Entertainment Acquisition Corp (Class A Stock) (SEAH), Supernova Partners Acquisition Company Inc (Class A Stock) (SPNV), Sypris Solutions (SYPR), Main Thematic Innovation (TMAT), TS Innovation Acquisition Corporation (Class A Stock) (TSIA), TWC Tech Holdings II Corporation (TWCT), Foley Trasimene Acquisition Corp (Class A Stock) (WPF), DPCM Capital Inc (Class A Stock) (XPOA), and Yalla Group Limited (Class A ADS) (YALA). Option delistings effective March 10th include NantKwest Inc (NK).

ShowHide Related Items >><<
YALA Yalla
$19.49 /

+1.57 (+8.76%)

WPF Foley Trasimene Acquisition Corp.
$10.20 /

+0.065 (+0.64%)

SYPR Sypris Solutions
$3.26 /

+0.16 (+5.16%)

RMGB RMG Acquisition Corporation II
$10.31 /

-0.13 (-1.25%)

RAAC Revolution Acceleration Acquisition Corp
$10.51 /

-0.04 (-0.38%)

ONCR Oncorus
$14.78 /

+0.72 (+5.12%)

NK NantKwest
$0.00 /

+ (+0.00%)

LCY Landcadia Holdings III
$10.40 /

+ (+0.00%)

IACA Ion Acquisition 1
$10.94 /

+0.15 (+1.39%)

HZON Horizon Acquisition Corp. II
$10.88 /

+0.01 (+0.09%)

GHVI Gores Holdings VI
$15.94 /

+1.3 (+8.88%)

DMYI dMY Technology Group, Inc. III
$11.31 /

+0.41 (+3.76%)

DCRB Decarbonization Plus Acquisition
$11.30 /

+0.5 (+4.63%)

BWAC Better World Acquisition
$9.99 /

+0.03 (+0.30%)

CONX Conx
$10.03 /

-0.08 (-0.79%)

DCRB Decarbonization Plus Acquisition
$11.30 /

+0.5 (+4.63%)

DMYI dMY Technology Group, Inc. III
$11.31 /

+0.41 (+3.76%)

GHVI Gores Holdings VI
$15.94 /

+1.3 (+8.88%)

GNRS Greenrose Acquisition
$10.04 /

+ (+0.00%)

HAAC Health Assurance Acquisition
$10.63 /

+0.14 (+1.33%)

HZON Horizon Acquisition Corp. II
$10.88 /

+0.01 (+0.09%)

IACA Ion Acquisition 1
$10.94 /

+0.15 (+1.39%)

IGAC IG Acquisition
$9.96 /

+0.04 (+0.40%)

LCY Landcadia Holdings III
$10.40 /

+ (+0.00%)

LEAP Ribbit LEAP
$11.96 /

+0.35 (+3.01%)

LFTR Lefteris Acquisition
$10.21 /

+0.01 (+0.10%)

LUXA Lux Health Tech Acquisition
$10.57 /

+0.06 (+0.57%)

MCMJ Merida Merger Corp. I
$10.09 /

+0.115 (+1.15%)

ONCR Oncorus
$14.78 /

+0.72 (+5.12%)

11/11/20 Piper Sandler
Oncorus timelines remain on track after Q3 results, says Piper Sandler
10/27/20 Jefferies
Oncorus initiated with a Buy at Jefferies
10/27/20 Evercore ISI
Oncorus initiated with an Outperform at Evercore ISI
10/27/20 Piper Sandler
Oncorus initiated with an Overweight at Piper Sandler
PIPP Pine Island Acquisition
$10.39 /

+0.07 (+0.68%)

RAAC Revolution Acceleration Acquisition Corp
$10.51 /

-0.04 (-0.38%)

RMGB RMG Acquisition Corporation II
$10.31 /

-0.13 (-1.25%)

SEAH Sports Entertainment Acquisition
$10.01 /

+0.01 (+0.10%)

SPNV Supernova Partners Acquisition
$10.30 /

+0.09 (+0.88%)

SYPR Sypris Solutions
$3.26 /

+0.16 (+5.16%)

TWCT TWC Tech Holdings II
$10.02 /

-0.085 (-0.84%)

WPF Foley Trasimene Acquisition Corp.
$10.20 /

+0.065 (+0.64%)

XPOA DPCM Capital
$10.12 /

-0.07 (-0.69%)

YALA Yalla
$19.49 /

+1.57 (+8.76%)

12/10/20 Oppenheimer
Yalla initiated with a Perform on valuation at Oppenheimer
12/10/20 Oppenheimer
Yalla initiated with a Perform at Oppenheimer
10/26/20 Morgan Stanley
Yalla initiated with an Equal Weight at Morgan Stanley
NK NantKwest
$0.00 /

+ (+0.00%)

07/08/20
Fly Intel: Top five analyst initiations
07/08/20 Piper Sandler
NantKwest initiated with an Overweight at Piper Sandler
ONCR Oncorus
$14.78 /

+0.72 (+5.12%)

  • 12
    Feb
  • 02
    Oct
  • 30
    Sep
  • 25
    Jun
XPOA DPCM Capital
$10.12 /

-0.07 (-0.69%)

SPNV Supernova Partners Acquisition
$10.30 /

+0.09 (+0.88%)

LEAP Ribbit LEAP
$11.96 /

+0.35 (+3.01%)

LCY Landcadia Holdings III
$10.40 /

+ (+0.00%)

HZON Horizon Acquisition Corp. II
$10.88 /

+0.01 (+0.09%)

GHVI Gores Holdings VI
$15.94 /

+1.3 (+8.88%)

DMYI dMY Technology Group, Inc. III
$11.31 /

+0.41 (+3.76%)

DCRB Decarbonization Plus Acquisition
$11.30 /

+0.5 (+4.63%)

PIPP Pine Island Acquisition
$10.39 /

+0.07 (+0.68%)

NK NantKwest
$0.00 /

+ (+0.00%)

LEAP Ribbit LEAP
$11.96 /

+0.35 (+3.01%)

LCY Landcadia Holdings III
$10.40 /

+ (+0.00%)

IACA Ion Acquisition 1
$10.94 /

+0.15 (+1.39%)

HZON Horizon Acquisition Corp. II
$10.88 /

+0.01 (+0.09%)

GHVI Gores Holdings VI
$15.94 /

+1.3 (+8.88%)

DCRB Decarbonization Plus Acquisition
$11.30 /

+0.5 (+4.63%)

CONX Conx
$10.03 /

-0.08 (-0.79%)

BWAC Better World Acquisition
$9.99 /

+0.03 (+0.30%)

Hot Stocks
Oncorus expects capital to be sufficient to fund requirements into late 2023 » 07:49
03/10/21
03/10
07:49
03/10/21
07:49
ONCR

Oncorus

$14.78 /

+0.72 (+5.12%)

Based upon its current…

Based upon its current operating plans and cash and cash equivalents at December 31, 2020, plus the net proceeds from the public offering of common stock in February 2021, the company expects to have sufficient capital to fund its operating expenses and capital expenditure requirements into late 2023.

ShowHide Related Items >><<
ONCR Oncorus
$14.78 /

+0.72 (+5.12%)

ONCR Oncorus
$14.78 /

+0.72 (+5.12%)

11/11/20 Piper Sandler
Oncorus timelines remain on track after Q3 results, says Piper Sandler
10/27/20 Jefferies
Oncorus initiated with a Buy at Jefferies
10/27/20 Evercore ISI
Oncorus initiated with an Outperform at Evercore ISI
10/27/20 Piper Sandler
Oncorus initiated with an Overweight at Piper Sandler
ONCR Oncorus
$14.78 /

+0.72 (+5.12%)

  • 12
    Feb
  • 02
    Oct
ONCR Oncorus
$14.78 /

+0.72 (+5.12%)

Hot Stocks
Oncorus to report interim data from Phase 1 trial of ONCR-177 in 2H21 » 07:48
03/10/21
03/10
07:48
03/10/21
07:48
ONCR

Oncorus

$14.78 /

+0.72 (+5.12%)

Oncorus anticipates…

Oncorus anticipates reporting interim data from its ongoing Phase 1 clinical trial of its lead oHSV-based clinical candidate ONCR-177 in patients with solid tumor indications in the second half of 2021 through the second half of 2022. The company plans to nominate its first synthetic virus clinical candidates, coxsackievirus A21 and Seneca Valley Virus programs, in the first half of 2021 and its second oHSV clinical candidate, which will specifically target brain cancer, including glioblastoma multiforme, in the second half of 2021.

ShowHide Related Items >><<
ONCR Oncorus
$14.78 /

+0.72 (+5.12%)

ONCR Oncorus
$14.78 /

+0.72 (+5.12%)

11/11/20 Piper Sandler
Oncorus timelines remain on track after Q3 results, says Piper Sandler
10/27/20 Jefferies
Oncorus initiated with a Buy at Jefferies
10/27/20 Evercore ISI
Oncorus initiated with an Outperform at Evercore ISI
10/27/20 Piper Sandler
Oncorus initiated with an Overweight at Piper Sandler
ONCR Oncorus
$14.78 /

+0.72 (+5.12%)

  • 12
    Feb
  • 02
    Oct
ONCR Oncorus
$14.78 /

+0.72 (+5.12%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.